Has Ian Gilchrist, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,450 in general payments to Ian Gilchrist, MD across 75 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ian Gilchrist, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ian Gilchrist, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ian Gilchrist, MD

Cardiovascular Disease · Lebanon, NHNPI 1306804943

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,400 of the $13,450 with a category attached, or 69.9%. 22 manufacturers reported payments, led by Terumo Medical Corporation at 51.6% of the total. Reporting peaked in 2019 at $3,957 and has fallen 68.1% since, to $1,263 in 2025. Among cardiovascular disease clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,450in general payments, 2019–2025

Across 75 payments — averaging $179.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Terumo Medical Corporation$7K
Cardinal Health 200 LLC$3K
Abbott$1K
Medtronic$545
Boston Scientific$485
E.r. Squibb & Sons, L.L.C.$237
plus $1K from 16 others

$112,613in research payments, 2019–2025

Across 96 payments — averaging $1173.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

CSL Behring$98K
M.a. Med Alliance S.A.$14K

What the payments were for

Consulting fees$9,40070%
Grants$270%
Food & beverage$4,02330%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Terumo Medical Corporation	11	$6,947
Cardinal Health 200 LLC	4	$3,114
Abbott	16	$1,039
Medtronic(2 entities)	9	$545
Boston Scientific	5	$485
E.r. Squibb & Sons, L.L.C.	2	$237
Chiesi USA, Inc.	8	$170
Biotronik Inc.	1	$127
Boehringer Ingelheim	1	$125
Shockwave Medical, Inc	2	$116
Penumbra, Inc.	2	$111
Teleflex LLC	1	$85
Cathworks, Inc.	1	$84
Cardiovascular Systems Inc.	1	$59
Amgen	1	$45
AstraZeneca	2	$38
Cook Medical LLC	2	$27
Abiomed	1	$26
Pfizer	1	$24
Edwards Lifesciences	1	$21
Philips North America LLC	1	$15
Cvrx, Inc.	2	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,450 in reported general payments places this provider in the 90th percentile of 112 cardiovascular disease providers in New Hampshire.

See all cardiovascular disease providers in New Hampshire →

Medicare billing

Part B allowed, 2024

$5,418

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metoprolol Succinate	13	$461
Atorvastatin Calcium	14	$315

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Lebanon

Kevin KwakuLebanon$79K
Michael YoungLebanon$53K
Merle MyersonLebanon$15K
Robert DangeloLebanon$10K
Rumman SyedLebanon$9K
Mohammadtokir MujtabaLebanon$8K
Lauren Gilstrap MilleyLebanon$5K
Fernando Contreras-ValdesLebanon$5K
David MinLebanon$3K
Monika BernasLebanon$3K

See the full list for New Hampshire →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →